fda bpc-157 category 2 bulk drug substance compounding list Exciting news for peptides coming out of today's committee hearing! The Pharmacy Advisory Committee voted 8-6 to recommend adding BPC- 157 to the 503A Bulks for use in compounding for FDA Peptide Reclassification 2026: What

FDA Peptide Reclassification 2026: What Researchers Want The FDA just dropped a 68 page PDF on if BPC 157 should be legal or not to compound. Their initial recommendation: DO NOT add BPC 157 to the 503A Bulks List. They're meeting this FDA Peptide Meeting Update: What People Should Know Olympia Pharmaceuticals FDA Peptide Reclassification 2026: What It Means for Providers

SKU: 77500255838 · From iglepidom.org